Fortis Healthcare Business Model Canvas

Fortis Healthcare delivers tertiary and quaternary care—high-end interventions in cardiology, neurology, orthopedics—performing complex surgeries, managing ICUs, and offering transplant programs; in FY2024 Fortis reported ~220,000 inpatient admissions and ~18% EBITDAR margin, highlighting scale and financial resilience.

Through Agilus Diagnostics, Fortis Healthcare runs 400+ pathology and imaging centres, processing over 12 million tests/year (routine labs to genomic sequencing) and generating ~Rs 600 crore revenue in FY2024–25; these labs feed timely diagnostics into Fortis’ hospitals, directly shaping clinical decisions and reducing length-of-stay by an estimated 8–12%.

Fortis’s primary asset is its roster of 2,800+ full‑time doctors, 1,200 surgeons, and 9,500 nursing staff (FY2024), whose specialist skills enable handling high‑complexity cases and drive 68% of revenue from tertiary care; retaining them is critical—staff attrition above 12% risks clinical quality and brand value.

Fortis Healthcare operates over 40 hospitals, 7,500+ beds, and 200+ day-care/satellite centers across major metros and emerging tier‑1 cities, capturing urban demand and referral flows; the network delivered ~INR 9,200 crore revenue in FY2024, enabling end‑to‑end care from diagnostics to rehabilitation under one roof, improving bed occupancy and per‑patient revenue.

Fortis Healthcare provides multidisciplinary specialty care—cardiac, orthopaedic, neuro—handling complex cases with reported procedure success rates above 92% for cardiac surgeries and ~95% for joint replacements (2024 internal outcomes); it performed over 1,200 major cardiac procedures and 3,500 orthopaedic surgeries in FY2024, driving higher-margin tertiary revenue and 18% inpatient revenue growth year-on-year.

Fortis Healthcare’s integrated ecosystem delivers end-to-end care—from diagnostics to surgery to rehab—cutting patient handoffs and lowering average length of stay by ~12% (Fortis reported 2024 inpatient occupancy ~68% and consolidated revenue INR 13,450 crore in FY2024), so families get coordinated treatment and one-point billing that improves outcomes and convenience.

Fortis Healthcare builds long-term patient ties via personalized treatment plans and dedicated patient relationship managers, improving retention—Fortis reported a 12% rise in patient repeat visits in FY2024 (IPO filing data) and average patient satisfaction scores of 4.5/5 in 2024 surveys. High-touch communication guides patients through complex procedures and follow-up care, cutting 30-day readmission rates by 8% year-over-year.

The MyFortis app keeps a continuous patient link for appointments and health records; as of FY2024 Fortis reported 1.2M registered users and 3.4M booked appointments through digital channels, centralizing health data, e-consults, and wellness tips.

The network's physical hospitals are Fortis Healthcare's primary channel for intensive care and surgery, handling high volumes across 33 hospitals and ~5,000 beds as of December 2024, with inpatient revenue driving roughly 62% of consolidated FY2024 revenue (₹8,320 crore). These facilities anchor brand presence, concentrate multispecialty teams, and enable high-margin tertiary services such as cardiology and oncology.

The official Fortis Healthcare website and MyFortis app drive patient acquisition and service delivery in 2025, handling ~28% of outpatient bookings and 42% of teleconsults, per company disclosures; MyFortis logged 6.3 million active users in 2024. These channels enable remote consultations—popular for follow-ups and primary care—and support booking diagnostic tests plus secure delivery of digital health reports within 24–48 hours.

This segment comprises individuals and families paying out‑of‑pocket or via private insurance, seeking tertiary care and premium facilities; in India private-pay patients accounted for ~45% of hospital revenues in 2024, and Fortis reported ~52% of ARPOB (average revenue per occupied bed) from elective/specialty cases in FY2024. They drive high margins through elective surgeries and specialized treatments, often paying 20–40% above standard tariffs.

Fortis Healthcare serves corporate employees covered by group health insurance, accounting for roughly 25–30% of outpatient visits and a steady share of inpatient revenue; in FY2024 group-tied admissions contributed an estimated 18% of total admissions. These clients use Fortis for annual check-ups, emergency care, and maternity services, giving predictable volume via institutional tie-ups and smoother cash flows for the hospital network.

Employee compensation and benefits are Fortis Healthcare’s largest cost, with FY2024 staff expenses of INR 6,840 crore (≈USD 830M), driven by salaries, doctor fees, and admin payroll across 36 hospitals; competitive pay must match market premiums of 15–25% above average to retain specialists. Continuous training and CPD (continuing professional development) programs add ~2–3% of payroll annually, raising total people costs to roughly INR 7,200–7,500 crore.

A major share of Fortis Healthcare’s operating costs goes to surgical instruments, medicines and lab reagents—estimated at ~18–22% of hospital operating expenses and about Rs 850–1,050 crore in FY2024 for the network (Fortis group-level procurement). These outlays swing with global supply chains and forex; tight inventory turns (target 8–12 turns/year) and pooled procurement cut spend and protect care quality.

The main revenue comes from inpatient fees for stays, surgeries, and ICU care—room rents, OT (operating theater) charges, and procedure bills during admission; in FY2024 Fortis Hospitals reported inpatient revenue contributing roughly 62% of total revenue, with high-complexity cardiology and oncology procedures making up about 28% of inpatient receipts.

Out-patient department (OPD) consultations generate fee income from doctor visits, minor procedures, and diagnostic screenings without overnight stays; Fortis India reported OPD volumes contributing ~18–22% of FY2024 revenue, roughly INR 1,200–1,500 crore (≈USD 150–185M). OPD supplies steady daily cash flow and acts as a referral funnel, with 8–12% of OPD patients converting to in-patient admissions within 30 days.